# reload+after+2024-01-23 12:47:52.657460
address1§100 Cambridgepark Drive
address2§Suite 101
city§Cambridge
state§MA
zip§02140
country§United States
phone§617 655 6580
website§https://www.vorbio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Vor Biopharma Inc., a clinical-stage company, engages in the development of engineered hematopoietic stem cell (eHSC) therapies for cancer patients. The company is developing lead product, tremtelectogene empogeditemcel (trem-cel), formerly VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. It also offers Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, currently under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system, currently under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system, made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, currently under preclinical studies for the treatment of AML. Vor Biopharma Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
fullTimeEmployees§133
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Robert  Ang M.B.A., M.D., MBBS', 'age': 48, 'title': 'President, CEO & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 875508, 'exercisedValue': 0, 'unexercisedValue': 2422002}, {'maxAge': 1, 'name': 'Dr. Nathan D. Jorgensen M.B.A., Ph.D.', 'age': 46, 'title': 'Chief Financial Officer', 'yearBorn': 1977, 'fiscalYear': 2022, 'totalPay': 608479, 'exercisedValue': 0, 'unexercisedValue': 548248}, {'maxAge': 1, 'name': 'Dr. Tirtha  Chakraborty Ph.D.', 'age': 50, 'title': 'Chief Scientific Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 622955, 'exercisedValue': 0, 'unexercisedValue': 418211}, {'maxAge': 1, 'name': 'Dr. Siddhartha  Mukherjee DPHIL, M.D., Ph.D.', 'age': 52, 'title': 'Scientific Founder & Chairman of Scientific Advisory Board', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Tania  Philipp', 'age': 51, 'title': 'Chief People Officer', 'yearBorn': 1972, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Robert G. Pietrusko Pharm. D., Pharm.D.', 'age': 75, 'title': 'Chief Regulatory Officer', 'yearBorn': 1948, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John C. King M.B.A.', 'age': 47, 'title': 'Chief Commercial Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Eyal C. Attar M.D.', 'age': 52, 'title': 'Chief Medical Officer', 'yearBorn': 1971, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Samir  Vattompadam M.S.', 'title': 'Senior Vice President of Portfolio Strategy & Program Management', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. David  Phillips M.B.A.', 'title': 'Senior VP & Head of Quality', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§8
boardRisk§6
compensationRisk§9
shareHolderRightsRisk§8
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.434
currency§USD
dateShortInterest§1702598400
forwardEps§-1.84
exchange§NMS
quoteType§EQUITY
shortName§Vor Biopharma Inc.
longName§Vor Biopharma Inc.
firstTradeDateEpochUtc§1612535400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§15672ec0-8f36-33f0-97ad-c393eafaad16
gmtOffSetMilliseconds§-18000000
targetHighPrice§22.0
targetLowPrice§10.0
targetMeanPrice§15.44
targetMedianPrice§16.25
recommendationMean§1.6
recommendationKey§buy
numberOfAnalystOpinions§8
quickRatio§10.404
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
